![]() ![]() The linkage between vitamin K and coagulation was further strengthened by the discovery of vitamin K-dependent (VKD) carboxylation of glutamic acid residues in prothrombin and other procoagulant and anticoagulant proteins 2. Vitamin K was identified as a fat-soluble factor that was required for preventing hemorrhages in chickens 1. These findings provide new insights into selectively controlling the physiological and pathological processes involving electron transfers mediated by vitamin K and ubiquinone. Intriguingly, dihydroorotate dehydrogenase, another ubiquinone-associated ferroptosis suppressor protein parallel to the function of FSP1, does not support vitamin K-dependent carboxylation. FSP1 inhibitor that inhibited ubiquinone reduction and thus triggered cancer cell ferroptosis, displays strong inhibition of vitamin K-dependent carboxylation. We find that ferroptosis suppressor protein 1 (FSP1), a ubiquinone oxidoreductase, is the enzyme responsible for vitamin K reduction in a warfarin-resistant manner, consistent with a recent discovery by Mishima et al. ![]() Here, we report the identification of warfarin-resistant vitamin K reductase using a genome-wide CRISPR-Cas9 knockout screen with a vitamin K-dependent apoptotic reporter cell line. Despite the functional discovery of vitamin K reductase over eight decades ago, its identity remained elusive. Patients overdosed on warfarin can be rescued by administering high doses of vitamin K because of the existence of a warfarin-resistant vitamin K reductase. Warfarin, a vitamin K antagonist, is the most commonly prescribed oral anticoagulant. Vitamin K is a vital micronutrient implicated in a variety of human diseases. A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |